XML 62 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 29, 2012
Dec. 31, 2011
Jan. 01, 2011
Operating Activities:      
Net income $ 354,259 $ 307,402 $ 264,890
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation, amortization and accretion 65,536 51,925 40,560
Stock-based compensation 18,568 14,615 10,553
Increase (decrease) in allowance for returns - net of inventory in transit 3,395 (700) 15,558
Loss on disposal of assets 2,290 2,582 748
Impairment losses 1,231 957 7,429
Equity in income of joint venture (1,382) (508) (1,072)
Distribution from joint venture 1,870 2,226 4,726
(Decrease) increase in allowance for doubtful accounts (1,221) 556 3,921
Excess tax benefits from stock-based compensation (11,693) (9,980) (11,961)
Deferred income taxes and other 10,591 29,697 11,213
Contingent consideration revaluation (9,949)    
Changes in operating assets and liabilities:      
Accounts receivable (42,849) (44,061) (85,893)
Inventories 10,677 (122,648) (115,921)
Prepaid expenses and other current assets 38,236 (34,029) (14,298)
Accounts payable (7,017) 12,657 18,193
Accrued expenses 2,847 34,094 63,331
Income taxes payable 16,211 6,482 (2,800)
Net cash provided by operating activities 451,600 251,267 209,177
Investing Activities:      
Additions to property, plant and equipment (112,385) (109,852) (46,538)
Increase in intangible and other assets (10,419) (21,644) (274)
Purchases of securities available for sale   (222) (628)
Sales/maturities of securities available for sale   8,255 314
Proceeds from sale of property, plant and equipment 68 21,388 448
Net change in restricted cash 6,734 (7,998)  
Other investing     (855)
Business acquisitions - net of cash acquired (229,151)    
Net cash used in investing activities (345,153) (110,073) (47,533)
Financing Activities:      
Acquisition of common stock (271,293) (270,882) (199,222)
Distribution of noncontrolling interest earnings (8,198) (9,373) (7,587)
Purchase of noncontrolling interest shares (14,061)    
Excess tax benefits from stock-based compensation 11,693 9,980 11,961
Borrowings on notes payable 554,568 12,883 1,243
Payments on notes payable (498,391) (8,838) (389)
Common stock issued upon legal settlement   7,833  
Proceeds from exercise of stock options 6,090 8,540 23,410
Net cash used in financing activities (219,592) (249,857) (170,584)
Effect of exchange rate changes on cash and cash equivalents 2,883 3,367 (3,441)
Net decrease in cash and cash equivalents (110,262) (105,296) (12,381)
Cash and cash equivalents:      
Beginning of year 287,498 392,794 405,175
End of year $ 177,236 $ 287,498 $ 392,794